🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase1/2, open label, multicenter study will assess the safety, tolera...
Status
Recruiting
Location
Mayo Clinic Hospital - Arizona
Start Date
2025-01-09
Trial ID
NCT06706076
Treatments Being Tested
This is an investigator-initiated clinical trial evaluating the safety, tol...
Status
Active Not Recruiting
Location
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2024-12-30
Trial ID
NCT07461181
Treatments Being Tested
The BRAVE is a phase II clinical trial aimed at evaluating the efficacy of ...
Status
Recruiting
Location
Vall d'Hebron Hospital
Start Date
2024-05-17
Trial ID
NCT06411600
Treatments Being Tested
The use of multiple drugs in a single clinical trial or as a therapeutic st...
Status
Completed
Location
Centre Hospitalier de Bretagne Sud - HÔPITAL DU SCORFF
Start Date
2013-10
Trial ID
NCT02022098
Treatments Being Tested
Mantle cell lymphoma (MCL) is a sub-type of non-Hodgkin's lymphoma (NHL) wh...
Status
Completed
Location
Stanford University Medical Center
Start Date
2009-08
Trial ID
NCT00490529
The goal of this single arm Phase I feasibility study is to investigate the...
Status
Terminated
Location
Columbia University Medical Center- Department of Radiation Oncology
Start Date
2018-03-19
Trial ID
NCT03246113
Treatments Being Tested
Advanced solid tumors remain a major therapeutic challenge due to their com...
Status
Recruiting
Location
West China Hospital, Sichuan University
Start Date
2026-06-05
Trial ID
NCT07567222
This is an open-label, dose escalation, multicenter, phase 1, first-in-huma...
Status
Recruiting
Location
Second Affiliated Hospital of Anhui Medical University
Start Date
2023-12-01
Trial ID
NCT06799637
Treatments Being Tested
This is a single-arm, open-label, Phase I study to evaluate the safety, tol...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-10-16
Trial ID
NCT07231081
Treatments Being Tested
In this study, 60 patients with HER2 overexpression UTUC with high-risk rec...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2024-02-20
Trial ID
NCT06210490
Treatments Being Tested